Sample Request

Global Continuous Glucose Monitoring (CGM) Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

SELECT LICENSE:

Published on 07/21/2020| Code: MAR41115D| Category: Utilities| Total Pages: 117

The Continuous Glucose Monitoring (CGM) market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Continuous Glucose Monitoring (CGM) market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Continuous Glucose Monitoring (CGM) market. The report focuses on well-known providers in the global Continuous Glucose Monitoring (CGM) industry, market segments, competition, and the macro environment.

Under COVID-19 Outbreak, how the Continuous Glucose Monitoring (CGM) Industry will develop is also analyzed in detail in Chapter 1.7 of the report.

In Chapter 2.4, we analyzed industry trends in the context of COVID-19.

In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.

In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.

In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Key players in the global Continuous Glucose Monitoring (CGM) market covered in Chapter 4:

Johnson & Johnson
Medtronic PLC
Echo Therapeutics, Inc
Pfizer Inc
Animas Corporation
Abbott Laboratories
Dexcom
Baxter International

In Chapter 11 and 13.3, on the basis of types, the Continuous Glucose Monitoring (CGM) market from 2015 to 2026 is primarily split into:

Transmitters & Receivers
Sensors
Insulin Pumps

In Chapter 12 and 13.4, on the basis of applications, the Continuous Glucose Monitoring (CGM) market from 2015 to 2026 covers:

Hospitals
Homecare Diagnostics
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:

North America (Covered in Chapter 6 and 13)

United States

Canada

Mexico

Europe (Covered in Chapter 7 and 13)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 8 and 13)

China

Japan

South Korea

Australia

India

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 9 and 13)

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Others

South America (Covered in Chapter 10 and 13)

Brazil

Argentina

Columbia

Chile

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2026

Table of Content

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Regulatory Scenario by Region/Country

1.4 Market Investment Scenario Strategic

1.5 Market Analysis by Type

1.5.1 Global Continuous Glucose Monitoring (CGM) Market Share by Type (2020-2026)

1.5.2 Transmitters & Receivers
1.5.3 Sensors
1.5.4 Insulin Pumps
1.6 Market by Application

1.6.1 Global Continuous Glucose Monitoring (CGM) Market Share by Application (2020-2026)

1.6.2 Hospitals
1.6.3 Homecare Diagnostics
1.6.4 Others
1.7 Continuous Glucose Monitoring (CGM) Industry Development Trends under COVID-19 Outbreak

1.7.1 Global COVID-19 Status Overview

1.7.2 Influence of COVID-19 Outbreak on Continuous Glucose Monitoring (CGM) Industry Development

2. Global Market Growth Trends

2.1 Industry Trends

2.1.1 SWOT Analysis

2.1.2 Porter’s Five Forces Analysis

2.2 Potential Market and Growth Potential Analysis

2.3 Industry News and Policies by Regions

2.3.1 Industry News

2.3.2 Industry Policies

2.4 Industry Trends Under COVID-19

3 Value Chain of Continuous Glucose Monitoring (CGM) Market

3.1 Value Chain Status

3.2 Continuous Glucose Monitoring (CGM) Manufacturing Cost Structure Analysis

3.2.1 Production Process Analysis

3.2.2 Manufacturing Cost Structure of Continuous Glucose Monitoring (CGM)

3.2.3 Labor Cost of Continuous Glucose Monitoring (CGM)

3.2.3.1 Labor Cost of Continuous Glucose Monitoring (CGM) Under COVID-19

3.3 Sales and Marketing Model Analysis

3.4 Downstream Major Customer Analysis (by Region)

3.5 Value Chain Status Under COVID-19

4 Players Profiles

4.1 Johnson & Johnson
4.1.1 Johnson & Johnson Basic Information
4.1.2 Continuous Glucose Monitoring (CGM) Product Profiles, Application and Specification
4.1.3 Johnson & Johnson Continuous Glucose Monitoring (CGM) Market Performance (2015-2020)
4.1.4 Johnson & Johnson Business Overview
4.2 Medtronic PLC
4.2.1 Medtronic PLC Basic Information
4.2.2 Continuous Glucose Monitoring (CGM) Product Profiles, Application and Specification
4.2.3 Medtronic PLC Continuous Glucose Monitoring (CGM) Market Performance (2015-2020)
4.2.4 Medtronic PLC Business Overview
4.3 Echo Therapeutics, Inc
4.3.1 Echo Therapeutics, Inc Basic Information
4.3.2 Continuous Glucose Monitoring (CGM) Product Profiles, Application and Specification
4.3.3 Echo Therapeutics, Inc Continuous Glucose Monitoring (CGM) Market Performance (2015-2020)
4.3.4 Echo Therapeutics, Inc Business Overview
4.4 Pfizer Inc
4.4.1 Pfizer Inc Basic Information
4.4.2 Continuous Glucose Monitoring (CGM) Product Profiles, Application and Specification
4.4.3 Pfizer Inc Continuous Glucose Monitoring (CGM) Market Performance (2015-2020)
4.4.4 Pfizer Inc Business Overview
4.5 Animas Corporation
4.5.1 Animas Corporation Basic Information
4.5.2 Continuous Glucose Monitoring (CGM) Product Profiles, Application and Specification
4.5.3 Animas Corporation Continuous Glucose Monitoring (CGM) Market Performance (2015-2020)
4.5.4 Animas Corporation Business Overview
4.6 Abbott Laboratories
4.6.1 Abbott Laboratories Basic Information
4.6.2 Continuous Glucose Monitoring (CGM) Product Profiles, Application and Specification
4.6.3 Abbott Laboratories Continuous Glucose Monitoring (CGM) Market Performance (2015-2020)
4.6.4 Abbott Laboratories Business Overview
4.7 Dexcom
4.7.1 Dexcom Basic Information
4.7.2 Continuous Glucose Monitoring (CGM) Product Profiles, Application and Specification
4.7.3 Dexcom Continuous Glucose Monitoring (CGM) Market Performance (2015-2020)
4.7.4 Dexcom Business Overview
4.8 Baxter International
4.8.1 Baxter International Basic Information
4.8.2 Continuous Glucose Monitoring (CGM) Product Profiles, Application and Specification
4.8.3 Baxter International Continuous Glucose Monitoring (CGM) Market Performance (2015-2020)
4.8.4 Baxter International Business Overview

5 Global Continuous Glucose Monitoring (CGM) Market Analysis by Regions

5.1 Global Continuous Glucose Monitoring (CGM) Sales, Revenue and Market Share by Regions

5.1.1 Global Continuous Glucose Monitoring (CGM) Sales by Regions (2015-2020)

5.1.2 Global Continuous Glucose Monitoring (CGM) Revenue by Regions (2015-2020)

5.2 North America Continuous Glucose Monitoring (CGM) Sales and Growth Rate (2015-2020)

5.3 Europe Continuous Glucose Monitoring (CGM) Sales and Growth Rate (2015-2020)

5.4 Asia-Pacific Continuous Glucose Monitoring (CGM) Sales and Growth Rate (2015-2020)

5.5 Middle East and Africa Continuous Glucose Monitoring (CGM) Sales and Growth Rate (2015-2020)

5.6 South America Continuous Glucose Monitoring (CGM) Sales and Growth Rate (2015-2020)

6 North America Continuous Glucose Monitoring (CGM) Market Analysis by Countries

6.1 North America Continuous Glucose Monitoring (CGM) Sales, Revenue and Market Share by Countries

6.1.1 North America Continuous Glucose Monitoring (CGM) Sales by Countries (2015-2020)

6.1.2 North America Continuous Glucose Monitoring (CGM) Revenue by Countries (2015-2020)

6.1.3 North America Continuous Glucose Monitoring (CGM) Market Under COVID-19

6.2 United States Continuous Glucose Monitoring (CGM) Sales and Growth Rate (2015-2020)

6.2.1 United States Continuous Glucose Monitoring (CGM) Market Under COVID-19

6.3 Canada Continuous Glucose Monitoring (CGM) Sales and Growth Rate (2015-2020)

6.4 Mexico Continuous Glucose Monitoring (CGM) Sales and Growth Rate (2015-2020)

7 Europe Continuous Glucose Monitoring (CGM) Market Analysis by Countries

7.1 Europe Continuous Glucose Monitoring (CGM) Sales, Revenue and Market Share by Countries

7.1.1 Europe Continuous Glucose Monitoring (CGM) Sales by Countries (2015-2020)

7.1.2 Europe Continuous Glucose Monitoring (CGM) Revenue by Countries (2015-2020)

7.1.3 Europe Continuous Glucose Monitoring (CGM) Market Under COVID-19

7.2 Germany Continuous Glucose Monitoring (CGM) Sales and Growth Rate (2015-2020)

7.2.1 Germany Continuous Glucose Monitoring (CGM) Market Under COVID-19

7.3 UK Continuous Glucose Monitoring (CGM) Sales and Growth Rate (2015-2020)

7.3.1 UK Continuous Glucose Monitoring (CGM) Market Under COVID-19

7.4 France Continuous Glucose Monitoring (CGM) Sales and Growth Rate (2015-2020)

7.4.1 France Continuous Glucose Monitoring (CGM) Market Under COVID-19

7.5 Italy Continuous Glucose Monitoring (CGM) Sales and Growth Rate (2015-2020)

7.5.1 Italy Continuous Glucose Monitoring (CGM) Market Under COVID-19

7.6 Spain Continuous Glucose Monitoring (CGM) Sales and Growth Rate (2015-2020)

7.6.1 Spain Continuous Glucose Monitoring (CGM) Market Under COVID-19

7.7 Russia Continuous Glucose Monitoring (CGM) Sales and Growth Rate (2015-2020)

7.7.1 Russia Continuous Glucose Monitoring (CGM) Market Under COVID-19

8 Asia-Pacific Continuous Glucose Monitoring (CGM) Market Analysis by Countries

8.1 Asia-Pacific Continuous Glucose Monitoring (CGM) Sales, Revenue and Market Share by Countries

8.1.1 Asia-Pacific Continuous Glucose Monitoring (CGM) Sales by Countries (2015-2020)

8.1.2 Asia-Pacific Continuous Glucose Monitoring (CGM) Revenue by Countries (2015-2020)

8.1.3 Asia-Pacific Continuous Glucose Monitoring (CGM) Market Under COVID-19

8.2 China Continuous Glucose Monitoring (CGM) Sales and Growth Rate (2015-2020)

8.2.1 China Continuous Glucose Monitoring (CGM) Market Under COVID-19

8.3 Japan Continuous Glucose Monitoring (CGM) Sales and Growth Rate (2015-2020)

8.3.1 Japan Continuous Glucose Monitoring (CGM) Market Under COVID-19

8.4 South Korea Continuous Glucose Monitoring (CGM) Sales and Growth Rate (2015-2020)

8.4.1 South Korea Continuous Glucose Monitoring (CGM) Market Under COVID-19

8.5 Australia Continuous Glucose Monitoring (CGM) Sales and Growth Rate (2015-2020)

8.6 India Continuous Glucose Monitoring (CGM) Sales and Growth Rate (2015-2020)

8.6.1 India Continuous Glucose Monitoring (CGM) Market Under COVID-19

8.7 Southeast Asia Continuous Glucose Monitoring (CGM) Sales and Growth Rate (2015-2020)

8.7.1 Southeast Asia Continuous Glucose Monitoring (CGM) Market Under COVID-19

9 Middle East and Africa Continuous Glucose Monitoring (CGM) Market Analysis by Countries

9.1 Middle East and Africa Continuous Glucose Monitoring (CGM) Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Continuous Glucose Monitoring (CGM) Sales by Countries (2015-2020)

9.1.2 Middle East and Africa Continuous Glucose Monitoring (CGM) Revenue by Countries (2015-2020)

9.1.3 Middle East and Africa Continuous Glucose Monitoring (CGM) Market Under COVID-19

9.2 Saudi Arabia Continuous Glucose Monitoring (CGM) Sales and Growth Rate (2015-2020)

9.3 UAE Continuous Glucose Monitoring (CGM) Sales and Growth Rate (2015-2020)

9.4 Egypt Continuous Glucose Monitoring (CGM) Sales and Growth Rate (2015-2020)

9.5 Nigeria Continuous Glucose Monitoring (CGM) Sales and Growth Rate (2015-2020)

9.6 South Africa Continuous Glucose Monitoring (CGM) Sales and Growth Rate (2015-2020)

10 South America Continuous Glucose Monitoring (CGM) Market Analysis by Countries

10.1 South America Continuous Glucose Monitoring (CGM) Sales, Revenue and Market Share by Countries

10.1.1 South America Continuous Glucose Monitoring (CGM) Sales by Countries (2015-2020)

10.1.2 South America Continuous Glucose Monitoring (CGM) Revenue by Countries (2015-2020)

10.1.3 South America Continuous Glucose Monitoring (CGM) Market Under COVID-19

10.2 Brazil Continuous Glucose Monitoring (CGM) Sales and Growth Rate (2015-2020)

10.2.1 Brazil Continuous Glucose Monitoring (CGM) Market Under COVID-19

10.3 Argentina Continuous Glucose Monitoring (CGM) Sales and Growth Rate (2015-2020)

10.4 Columbia Continuous Glucose Monitoring (CGM) Sales and Growth Rate (2015-2020)

10.5 Chile Continuous Glucose Monitoring (CGM) Sales and Growth Rate (2015-2020)

11 Global Continuous Glucose Monitoring (CGM) Market Segment by Types

11.1 Global Continuous Glucose Monitoring (CGM) Sales, Revenue and Market Share by Types (2015-2020)

11.1.1 Global Continuous Glucose Monitoring (CGM) Sales and Market Share by Types (2015-2020)

11.1.2 Global Continuous Glucose Monitoring (CGM) Revenue and Market Share by Types (2015-2020)

11.2 Transmitters & Receivers Sales and Price (2015-2020)
11.3 Sensors Sales and Price (2015-2020)
11.4 Insulin Pumps Sales and Price (2015-2020)

12 Global Continuous Glucose Monitoring (CGM) Market Segment by Applications

12.1 Global Continuous Glucose Monitoring (CGM) Sales, Revenue and Market Share by Applications (2015-2020)

12.1.1 Global Continuous Glucose Monitoring (CGM) Sales and Market Share by Applications (2015-2020)

12.1.2 Global Continuous Glucose Monitoring (CGM) Revenue and Market Share by Applications (2015-2020)

12.2 Hospitals Sales, Revenue and Growth Rate (2015-2020)
12.3 Homecare Diagnostics Sales, Revenue and Growth Rate (2015-2020)
12.4 Others Sales, Revenue and Growth Rate (2015-2020)

13 Continuous Glucose Monitoring (CGM) Market Forecast by Regions (2020-2026)

13.1 Global Continuous Glucose Monitoring (CGM) Sales, Revenue and Growth Rate (2020-2026)

13.2 Continuous Glucose Monitoring (CGM) Market Forecast by Regions (2020-2026)

13.2.1 North America Continuous Glucose Monitoring (CGM) Market Forecast (2020-2026)

13.2.2 Europe Continuous Glucose Monitoring (CGM) Market Forecast (2020-2026)

13.2.3 Asia-Pacific Continuous Glucose Monitoring (CGM) Market Forecast (2020-2026)

13.2.4 Middle East and Africa Continuous Glucose Monitoring (CGM) Market Forecast (2020-2026)

13.2.5 South America Continuous Glucose Monitoring (CGM) Market Forecast (2020-2026)

13.3 Continuous Glucose Monitoring (CGM) Market Forecast by Types (2020-2026)

13.4 Continuous Glucose Monitoring (CGM) Market Forecast by Applications (2020-2026)

13.5 Continuous Glucose Monitoring (CGM) Market Forecast Under COVID-19

14 Appendix

14.1 Methodology

14.2 Research Data Source

Our Clients

BIC
Suntory Holdings
Continental AG
Ernst Klett
felix
IF Logo
ITC logo
jc
KB
KKR
LR
LSC
Prospect
SRG
Sumitomo
Taichin logo
The Cleanest Way
Meat & Livestock Australia Limited
LEK
IFFCO
STTS
Laundry Capital LLC
Chippenhook Corporation
SAB
IJIN
Hooton
Medica
Medalliacne
Shanghai Chenzhu Instrument Co., Ltd.
Sanofi
Kleen Linnebo und Partner GbR
Bond-Pro, Inc.
E&L Faster Food Imports Inc.
Okinawa Institute of Science and Technology
Mizuno Corp

Need Help?

Please fill form below:

Contact Us

99 WALL STREET #2124 NEW YORK, NY 10005